drugset / Trial / NCT07583134

Impact of Propranolol Strategies on Myocardial Injury After Breast Cancer Surgery

NCT07583134

Phase 4 Not yet recruiting 100 enrolled Chang-Ik Yoon Seoul St. Mary's Hospital · collab
RandomizedParallel-groupOpen-labelPrevention

Summary

This study aims to evaluate the impact of using propranolol, a non-selective beta-blocker, on preventing myocardial injury after non-cardiac surgery (MINS) in breast cancer patients who also have hypertension or angina. Stress from surgery and anesthesia can increase sympathetic activity and inflammation, which may lead to heart stress. This pragmatic clinical trial will compare patients who are prescribed propranolol as part of their routine care with those who are not. Researchers will analyze blood samples and surgical tissues collected during normal treatment to observe changes in heart health and the tumor microenvironment.

Timeline

Start
2026-05-26
Primary completion
2028-05-23
Completion
2033-05-24

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Propranolol Small molecule